TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties.

Saved in:
Bibliographic Details
Title: TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties.
Authors: Goh, K C1, Novotny-Diermayr, V1, Hart, S1, Ong, L C1, Loh, Y K1, Cheong, A1, Tan, Y C1, Hu, C1, Jayaraman, R1, William, A D1, Sun, E T1, Dymock, B W1, Ong, K H2, Ethirajulu, K1, Burrows, F3, Wood, J M1
Source: Leukemia (08876924). Feb2012, Vol. 26 Issue 2, p236-243. 8p. 2 Black and White Photographs, 1 Diagram, 1 Chart, 4 Graphs.
Database: Academic Search Ultimate
Description
ISSN:08876924
DOI:10.1038/leu.2011.218